Getting to the Heart of Type 2 Diabetes Care:
Seeking Better Outcomes in Patients with Cardiovascular Disease
Release Date: December 28, 2017
Last Reviewed: December 24, 2017
Expiration Date: December 28, 2018
Time to Complete Activity:  1.25 hours
*This activity expired for credit on December 28, 2018 and is no longer available for credit
This activity is provided by Paradigm Medical Communications, LLC.
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital and Heart and Vascular Center
Professor of Medicine
Harvard Medical School
Boston, MA

Vivian A. Fonseca, MD, FRCP
Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Tulane University
New Orleans, LA
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in cardiology. This activity will also be of benefit to nurse practitioners and PAs, as well as other healthcare providers interested in the management of patients with cardiovascular disease and diabetes.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Assess data about the extraglycemic effects of type 2 diabetes therapies, with an emphasis on cardiovascular outcomes.
  • Review current guideline recommendations and available data to support appropriate individualized type 2 diabetes management in patients with cardiovascular disease.
  • Identify strategies for improving communication with patients and with other healthcare providers involved in the care of patients with type 2 diabetes mellitus and cardiovascular disease.
Table of Contents
  • Introduction
  • Putting Antihyperglycemic Cardiovascular Outcomes Studies in Context With Clinical Practice
  • Managing Hyperglycemia in the Cardiology Practice: Understanding Mechanisms Underlying the Cardiovascular Effects of Antihyperglycemic Agents
  • ADA 2017 Guideline Recommendations on Diabetes Care
  • Multidisciplinary Care of T2D Patients: Collaborative Strategies to Improve Patient Outcomes
  • Q&A
Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation Statement
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Novo Nordisk Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
  • A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 audio.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues email us at

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Advisory Board: Cardax, Inc. Elsevier PracticeUpdate® Cardiology, Medscape Cardiology, Regado Biosciences, Inc.
Board of Directors: Boston VA Research Institute, Inc.; Society of Cardiovascular Patient Care
Chair: American Heart Association Quality Oversight Committee
Data Monitoring Committees: Cleveland Clinic; Duke Clinical Research Institute; Harvard Clinical Research Institute; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Population Health Research Institute
Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News,; Belvoir Media Group, LLC. (Editor in Chief, Harvard Heart Letter); Duke Clinical Research Institute (clinical trial steering committees); Harvard Clinical Research Institute (clinical trial steering committee); HMP Communications LLC (Editor in Chief, Journal of Invasive Cardiology); Journal of the American College of Cardiology (Guest Editor; Associate Editor); Population Health Research Institute (clinical trial steering committee); Slack Incorporated (Chief Medical Editor, Cardiology Today’s Intervention); Society of Cardiovascular Patient Care (Secretary/Treasurer); WebMD (CME steering committees)
Other: Clinical Cardiology (Deputy Editor); NCDR-ACTION Registry Steering Committee (Chair); VA CART Research and Publications Committee (Chair)
Research Funding: Amarin Corporation; Amgen Inc; AstraZeneca; Bristol-Myers Squibb Company; CHIESI USA, Inc.; Eisai, Inc; Ethicon US, LLC.; Forest Laboratories, Inc; Ironwood Pharmaceuticals, Inc; Ischemix, Inc.; Eli Lilly and Company; Medtronic; Pfizer Inc; Roche; sanofi-aventis U.S. LLC; The Medicines Company
Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease)
Site Co-Investigator: Biotronik, Boston Scientific Corporation; St. Jude Medical, LLC (now Abbott)
Trustee: American College of Cardiology
Unfunded Research: FlowCo, Inc., Merck & Co., Inc; PLx Pharma Inc.; Takeda Pharmaceutical Company Ltd

Vivian A. Fonseca, MD, FRCP
Grant/Research Support: AsahiKASEI; Bayer
Retained Consultant: AstraZeneca; Eli Lilly and Company; Janssen Pharmaceuticals, Inc; Novo Nordisk Inc.;
sanofi-aventis U.S., LLC.; Takeda Pharmaceutical Company Ltd
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC, are committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at
© 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.